Related Experiment Video
Updated: Jul 4, 2026

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
Chia-Chi Lin1, Yeong-Shiau Pu, Chih-Hung Hsu
1Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Abstract:
There have been no prior reports of central nervous system toxicity following arsenic trioxide in patients with solid tumors. We report three metastatic urothelial carcinoma patients who were treated with arsenic trioxide (0.24 mg/kg/d 3-hour intravenously on days 1-6 weekly for 4 of every 5 weeks) who developed a clinical symptom complex characterized by confusion, word-finding difficulty, and behavioral changes. These symptoms appeared between day 26 and day 45 and resolved spontaneously in 1 patient. Two patients' symptoms did not resolve and they died of progressive urothelial carcinoma on days 47 and 90, respectively. Neuroimaging, lumbar puncture, and laboratory investigations did not reveal other causes. Arsenic trioxide in this dose and schedule can cause acute encephalopathy in patients with metastatic urothelial carcinoma who have received previous chemotherapy.
Related Concept Videos
Hepatic Encephalopathy
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Encephalitis l: Introduction
Acute Kidney Injury III: Clinical Manifestations
Drug Toxicity: Risk factors
Chronic Kidney Disease II: Clinical Manifestations
